You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股午評:三大指數齊跌,醫藥股逆勢走強,兩市3600股下跌

指數弱勢震盪,滬指午間收跌0.54%報3253點,深成指跌0.93%,盤中一度跌逾2%的創業板指最終跌0.8%。兩市970股上漲,3610股下跌,成交額5700億,北上資金淨賣出16.6億。

行業板塊多數下跌,科技股成下跌主力,電子身份證、數字貨幣、東數西算、第三代半導體等概念大跌靠前,白酒股普跌,山西汾酒跌逾3%。煤炭股繼續走強,兗礦能源漲4.4%;醫藥股強勁,CXO、仿製藥、幽門螺桿菌概念漲幅靠前,藥明康德續漲4%;磷化工、醫美、新冠檢測等概念活躍。

煤炭股再度走強,兗礦能源漲4%。海通證券指出,從1-2月數據看,煤炭產量增幅遠高於需求增速,但煤價依然穩中有升,反映供需整體仍偏緊。考慮到全球煤炭資源緊張、俄烏局勢等情況,能源安全必將得到進一步重視,因此增產保供基調或貫穿全年,預計全年煤炭產量增速在去年高基數情況下仍有望穩健增長。

醫藥股強勁,CXO、疫苗等概念股大漲,藥明康德漲4%。近日,國家衞健委發佈《新型冠狀病毒肺炎診療方案(試行第九版)》,在核酸檢測基礎上,增加抗原檢測作為補充,將輝瑞新冠口服藥Paxlovid和騰盛博藥中和抗體加入診療方案,對中醫治療內容進行了修訂完善。平安證券指,此次診療方案的更改進一步提高我國應對新冠疫情的防控效率,儘可能降低疫情持續爆發對於社會的負面影響。基於我國龐大的人口基數,相應的新冠藥和抗原檢測具有較大市場空間,利好相關生產及產業鏈企業的業績表現。

氫能源概念股走勢分化,雪人股份再漲6%。此前,發改委發佈《氫能產業發展中長期規劃(2021-2035年)》提出:支持符合條件的氫能企業在科創板、創業板等註冊上市融資;探索在氫能應用規模較大的地區設立制氫基地;開展氫儲能在可再生能源消納、電網調峯等應用場景的示範;逐步建立燃料電池電動汽車與鋰電池純電動汽車的互補發展模式;打造氫能產業發展“1+N”政策體系等。

國盛證券指,市場在經歷短線快速下殺後,回踩2020年7月以來的的箱體底部後,短線已經連續開啟修復性反彈,可積極跟蹤市場資金關注度較高板塊個股低吸機會。整體看,市場流動性總體穩定的基調下,可積極關注當前市場熱門的房地產板塊、已經經歷大幅估值壓縮的成長類個股。

操作上,隨着“兩會”後相關政策的逐步落地,且經歷快速估值壓縮後,市場各個題材具備短線反彈空間,可積極關注成長股的低吸機會,以及在修復性反彈中的超跌反彈個股機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account